Is smoking associated with the risk of developing Alzheimer's disease? Results from three Canadian data sets

被引:23
作者
Tyas, SL
Pederson, LL
Koval, JJ
机构
[1] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada
[2] Morehouse Sch Med, Dept Community Hlth & Prevent Med, Atlanta, GA USA
关键词
Alzheimer's disease; risk factors; smoking;
D O I
10.1016/S1047-2797(00)00061-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PURPOSE: To determine whether smoking is associated with Alzheimer's disease (AD). METHODS: Analyses were conducted using three Canadian data sets: the University of Western Ontario Dementia Study (200 cases, 163 controls), the Canadian Study of Health and Aging (258 cases, 258 controls), and the patient database from the Clinic for Alzheimer Disease and Related Disorders at the Vancouver Hospital and Health Sciences Centre (566 cases, 277 controls). The association between smoking and AD was investigated using bivariate analyses and multiple logistic regression models adjusted for the potential confounders age, sex, educational revel, family history of dementia, head injury, and hypertension. RESULTS: The results of bivariate analyses were inconsistent across the three data sets, with smoking status a significant protective factor, a significant risk factor, or not associated with AD. The results of multiple logistic regression models, however, were consistent: any association between smoking status and AD disappeared in all three data sets after adjustment for confounders. CONCLUSIONS: Smoking status was consistently not associated with AD across all three data sets after adjustment for confounders. Failure to adjust for relevant confounders may explain inconsistent reports of the influence of smoking on AD. Any protective effect of smoking may be limited to specific AD subtypes (e.g., early onset AD). Ann Epidemiol 2000;10:409-416. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 42 条
[11]  
Kleinbaum D.G., 1994, LOGISTIC REGRESSION
[12]   SMOKING AND ALZHEIMERS-DISEASE - A REVIEW OF THE EPIDEMIOLOGIC EVIDENCE [J].
LEE, PN .
NEUROEPIDEMIOLOGY, 1994, 13 (04) :131-144
[13]   Exploring the etiology of Alzheimer disease using molecular genetics [J].
Lendon, CL ;
Ashall, F ;
Goate, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (10) :825-831
[14]  
Letenneur Luc, 1994, Annals of Epidemiology, V4, P449
[15]  
MCDOWELL I, 1994, CAN MED ASSOC J, V150, P899
[16]  
MCDOWELL I, 1994, NEUROLOGY, V44, P2073
[17]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[18]   CORRELATIVE STUDIES IN ALZHEIMERS-DISEASE [J].
MERSKEY, H ;
BLUME, WT ;
COLHOUN, EH ;
FISMAN, M ;
FOX, AJ ;
FOX, H ;
HACHINSKI, VC ;
KRAL, VA ;
RYLETT, RJ ;
SMITH, R .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1985, 9 (5-6) :509-514
[19]  
MORTIMER JA, 1995, RESEARCH ADVANCES IN ALZHEIMER'S DISEASE AND RELATED DISORDERS, P3
[20]   HOMOGENEITY OF VARIANCE IN THE 2-SAMPLE MEANS TEST [J].
MOSER, BK ;
STEVENS, GR .
AMERICAN STATISTICIAN, 1992, 46 (01) :19-21